Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NGRN pseudogene 4 (NGRNP4)
- Target
- NGRNP4
- Molecular classification
- Pseudogene, Long non-coding RNA
01
Overview
NGRN pseudogene 4 (NGRNP4) is mapped to human chromosome 6 and annotated as a pseudogene of the neurogranin (NGRN) gene[3]. Pseudogenes are DNA sequences similar to known genes but are typically transcriptionally silent or produce non-coding RNA, not functional protein. Some pseudogenes, generally, may be transcribed into long non-coding RNAs (lncRNAs) and could influence the expression of their parental genes via microRNA competition or other regulatory mechanisms (the so-called competitive endogenous RNA, or ceRNA, network). However, there is currently no functional or disease-relevant role specifically assigned to NGRN pseudogene 4, and it is not considered a therapeutic target[1][2][3].
- Other names
- NGRNP4
02
Biological functions
May participate in regulation of parental gene expression via non-coding RNA mechanisms, such as acting as a competitive endogenous RNA (ceRNA) in microRNA networks (general function for some pseudogenes, not specifically validated for NGRNP4)
03
Disease associations
Other (no specific disease association or role established for NGRN pseudogene 4 itself)
Beyond the preview
Go deeper on NGRN pseudogene 4 (NGRNP4).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NGRN pseudogene 4 (NGRNP4).